| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |